Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IN RE: CERTAIN CONSOLIDATED ZOLEDRONIC ACID CASES
Case Number:
2:12-cv-03967
Court:
Nature of Suit:
Judge:
Firms
- Axinn Veltrop
- Buchanan Ingersoll
- Connell Foley
- Cozen O'Connor
- Eckert Seamans
- Epstein Becker
- Flaster Greenberg
- Fleming Ruvoldt
- Fox Rothschild
- Goldberg Segalla
- Haug Partners
- Hunton Andrews
- Kasowitz Benson
- Kenyon & Kenyon
- K&L Gates
- Kramer Alberti
- McCarter & English
- Midlige Richter
- Panitch Schwarze
- Parker Ibrahim
- Patunas Law
- Rivkin Radler
- Robinson Miller
- Saiber LLC
- Schnader Harrison
- Windels Marx
Companies
- Akorn Inc.
- Allergan PLC
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Fresenius Kabi AG
- Gland Pharma Ltd.
- Hospira Inc.
- Mylan NV
- Novartis AG
- Par Pharmaceutical Cos. Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Wockhardt Ltd.
- Wockhardt USA LLC
Sectors & Industries:
-
January 14, 2016
Novartis, Actavis Settle Patent Infringement Suit
Novartis Pharmaceuticals Corp. and Actavis LLC have agreed to settle claims that the generic drug maker's use of a drug ingredient infringed Novartis' patents, according to a court documents filed in New Jersey federal court on Thursday.
-
October 23, 2013
Generics Cos. Can't Pare Novartis Patent Infringement Suit
A New Jersey federal judge on Wednesday denied a bid by Apotex Inc. and other generic-drug makers to trim Novartis Pharmaceuticals Corp.'s suit against them, saying it was too early in the proceeding to determine whether their use of a drug ingredient infringed Novartis' patents.
-
May 01, 2013
Generics Co. Rips Novartis' Bid To Combine Reclast Suits
Wockhardt USA LLC told a New Jersey federal judge Tuesday that three patent infringement suits launched by Novartis Pharmaceuticals Corp. seeking to block drugmakers from developing generic versions of its osteoporosis drug Reclast and oncology drug Zometa should be tried separately.